[HTML][HTML] Mesenchymal stromal cells: putative microenvironmental modulators become cell therapy

M Krampera, K Le Blanc - Cell stem cell, 2021 - cell.com
An exceptional safety profile has been shown in a large number of cell therapy clinical trials
that use mesenchymal stromal cells (MSCs). However, reliable potency assays are still …

Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?

T Burnouf, D Strunk, MBC Koh, K Schallmoser - Biomaterials, 2016 - Elsevier
The essential physiological role of platelets in wound healing and tissue repair builds the
rationale for the use of human platelet derivatives in regenerative medicine. Abundant …

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase …

J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans… - Cytotherapy, 2016 - Elsevier
Mesenchymal stromal cells (MSCs) as a pharmaceutical for ailments characterized by
pathogenic autoimmune, alloimmune and inflammatory processes now cover the spectrum …

Spheroid culture of mesenchymal stem cells

Z Cesarz, K Tamama - Stem cells international, 2016 - Wiley Online Library
Compared with traditional 2D adherent cell culture, 3D spheroidal cell aggregates, or
spheroids, are regarded as more physiological, and this technique has been exploited in the …

Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells

P Mattar, K Bieback - Frontiers in immunology, 2015 - frontiersin.org
Mesenchymal stromal cells (MSC) have gained immense attraction in regenerative
medicine, tissue engineering, and immunotherapy. This is based on their differentiation …

Increased mesenchymal stem cell functionalization in three-dimensional manufacturing settings for enhanced therapeutic applications

D Kouroupis, D Correa - Frontiers in bioengineering and …, 2021 - frontiersin.org
Mesenchymal stem/stromal cell (MSC) exist within their in vivo niches as part of
heterogeneous cell populations, exhibiting variable stemness potential and supportive …

Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells

M Najar, G Raicevic, H Fayyad-Kazan, D Bron… - Cytotherapy, 2016 - Elsevier
Because of their well-recognized immunomodulatory properties, mesenchymal stromal cells
(MSCs) represent an attractive cell population for therapeutic purposes. In particular, there is …

Concise review: stem cell therapy for stroke patients: are we there yet?

CV Borlongan - Stem Cells Translational Medicine, 2019 - academic.oup.com
Four decades of preclinical research demonstrating survival, functional integration, and
behavioral effects of transplanted stem cells in experimental stroke models have provided …

Mesenchymal stem cells as a cornerstone in a galaxy of intercellular signals: basis for a new era of medicine

S Fernández-Francos, N Eiro, LA Costa… - International journal of …, 2021 - mdpi.com
Around 40% of the population will suffer at some point in their life a disease involving tissue
loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with …

[HTML][HTML] Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications …

M Monguió-Tortajada, S Roura, C Gálvez-Montón… - Theranostics, 2017 - ncbi.nlm.nih.gov
Undesired immune responses have drastically hampered outcomes after allogeneic organ
transplantation and cell therapy, and also lead to inflammatory diseases and autoimmunity …